Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Evgeny Klyuchnikov, Svetlana Asenova, Wolfgang Kern, Gökhan Kilinc, Francis Ayuk, Bettina Wiedemann, Michael Lioznov, Petra Freiberger, Yuriy Zalyalov, Axel Rolf Zander, Nicolaus Kröger & Ulrike Bacher. (2010) Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia. Leukemia & Lymphoma 51:8, pages 1450-1463.
Read now
Read now
Articles from other publishers (16)
Emilia Salzmann-Manrique, Melanie Bremm, Sabine Huenecke, Milena Stech, Andreas Orth, Matthias Eyrich, Ansgar Schulz, Ruth Esser, Thomas Klingebiel, Peter Bader, Eva Herrmann & Ulrike Koehl. (2018) Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study. Frontiers in Immunology 9.
Crossref
Crossref
Sandeep Soni, Hisham Abdel-Azim, Meghann McManus, Eneida Nemecek, Richard Sposto, Ann Woolfrey & Haydar Frangoul. (2017) Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study. Biology of Blood and Marrow Transplantation 23:7, pages 1134-1141.
Crossref
Crossref
Juan Gea-Banacloche, Krishna V. Komanduri, Paul Carpenter, Sophie Paczesny, Stefanie Sarantopoulos, Jo-Anne Young, Nahed El Kassar, Robert Q. Le, Kirk R. Schultz, Linda M. Griffith, Bipin N. Savani & John R. Wingard. (2017) National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. Biology of Blood and Marrow Transplantation 23:6, pages 870-881.
Crossref
Crossref
F. Jenhani, Z. Regaya, L. Berraies & F. Mellouli. (2017) Immune and Hematological Reconstitution after Allogenic Bone Marrow Transplantation in Tunisian Pediatric Recipients: Prospective Study and Tunisian Experience Report. Journal of Hematology Research 4, pages 26-34.
Crossref
Crossref
Eun-Ji Choi, Je-Hwan Lee, Jung-Hee Lee, Dae-Young Kim, Han-Seung Park, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon & Kyoo-Hyung Lee. (2016) Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5 %—a feasibility study. Annals of Hematology 95:7, pages 1151-1161.
Crossref
Crossref
Andrew R. Rezvani & H. Joachim Deeg. 2016. Transplant Infections. Transplant Infections
3
17
.
Seung-Hwan Shin, Jung-Ho Kim, Young-Woo Jeon, Jae-Ho Yoon, Seung-Ah Yahng, Sung-Eun Lee, Yun-Suk Choi, Dae-Young Kim, Jung-Hee Lee, Seok Lee, Hee-Je Kim, Chang-Ki Min, Jong-Wook Lee, Kyoo-Hyung Lee, Woo-Sung Min, Yoo-Jin Kim & Je-Hwan Lee. (2015) Feasible Outcomes of T Cell–Replete Haploidentical Stem Cell Transplantation with Reduced-Intensity Conditioning in Patients with Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation 21:2, pages 342-349.
Crossref
Crossref
Mark H. Kirschbaum, Anthony S. Stein, Leslie Popplewell, Maria Delioukina, Robert Chen, Ryotaro Nakamura, David Snyder, Joel Conrad, Simon F. Lacey, Paul Frankel, Andrew Dagis, Auayporn Nademanee & Stephen J. Forman. (2012) A Phase I Study in Adults of Clofarabine Combined with High-Dose Melphalan as Reduced-Intensity Conditioning for Allogeneic Transplantation. Biology of Blood and Marrow Transplantation 18:3, pages 432-440.
Crossref
Crossref
Mark B. Geyer, Judith S. Jacobson, Jason Freedman, Diane George, Virginia Moore, Carmella van de Ven, Prakash Satwani, Monica Bhatia, James H. Garvin, Mary Brigid Bradley, Lauren Harrison, Erin Morris, Phyllis Della-Latta, Joseph Schwartz, Lee A. Baxter-Lowe & Mitchell S. Cairo. (2011) A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. British Journal of Haematology 155:2, pages 218-234.
Crossref
Crossref
Shih Hann Su, Valérie Martel-Laferrière, Annie-Claude Labbé, David R. Snydman, David Kent, Michel Laverdière, Claire Béliveau, Tanya Logvinenko, Sandra Cohen, Silvy Lachance, Thomas Kiss & Jean Roy. (2011) High Incidence of Herpes Zoster in Nonmyeloablative Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 17:7, pages 1012-1017.
Crossref
Crossref
Martin Schmidt-Hieber, S. Schwarck, A. Stroux, S. Ganepola, P. Reinke, E. Thiel, L. Uharek & I. W. Blau. (2010) Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion. International Journal of Hematology 91:5, pages 877-885.
Crossref
Crossref
A. Grigg & M. Slavin. (2008) Minimizing the risk of recurrent or progressive invasive mold infections during stem cell transplantation or further intensive chemotherapy. Transplant Infectious Disease 10:1, pages 3-12.
Crossref
Crossref
Janne M. Nestvold, Bente K. Omdal, Ke-Zheng Dai, Anton Martens, Haakon B. Benestad, John T. Vaage & Bent Rolstad. (2008) A Second Prophylactic MHC-Mismatched Bone Marrow Transplantation Protects Against Rat Acute Myeloid Leukemia (BNML) Without Lethal Graft-Versus-Host Disease. Transplantation 85:1, pages 102-111.
Crossref
Crossref
M Jiménez, G Ercilla & C Martínez. (2007) Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia 21:8, pages 1628-1637.
Crossref
Crossref
C Heining, A Spyridonidis, E Bernhardt, J Schulte-Mönting, D Behringer, C Grüllich, A Jakob, H Bertz & J Finke. (2007) Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Bone Marrow Transplantation 39:10, pages 613-622.
Crossref
Crossref
. (2006) Current Awareness in Hematological Oncology. Hematological Oncology 24:1, pages 38-45.
Crossref
Crossref